Seres Therapeutics (MCRB) Revenue & Revenue Breakdown
Seres Therapeutics Revenue Highlights
Latest Revenue (Y)
$126.33M
Main Segment (Y)
License And Service
Main Geography (Y)
License And Service
Seres Therapeutics Revenue by Period
Seres Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $126.33M | 1672.24% |
| 2022-12-31 | $7.13M | -95.08% |
| 2021-12-31 | $144.93M | 336.33% |
| 2020-12-31 | $33.22M | -3.74% |
| 2019-12-31 | $34.51M | 22.07% |
| 2018-12-31 | $28.27M | -11.94% |
| 2017-12-31 | $32.10M | 47.48% |
| 2016-12-31 | $21.77M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Seres Therapeutics generated $126.33M in revenue during NA 2023, up 1672.24% compared to the previous quarter, and up 446.90% compared to the same period a year ago.
Seres Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $64.00K | -79.35% |
| 2023-09-30 | $310.00K | -99.75% |
| 2023-06-30 | $126.47M | -24328.54% |
| 2023-03-31 | $-522.00K | -153.54% |
| 2022-12-31 | $975.00K | -71.69% |
| 2022-09-30 | $3.44M | 183.22% |
| 2022-06-30 | $1.22M | -18.55% |
| 2022-03-31 | $1.49M | -79.32% |
| 2021-12-31 | $7.22M | -94.30% |
| 2021-09-30 | $126.72M | 2307.85% |
| 2021-06-30 | $5.26M | -7.96% |
| 2021-03-31 | $5.72M | -67.44% |
| 2020-12-31 | $17.56M | 1139.52% |
| 2020-09-30 | $1.42M | -76.56% |
| 2020-06-30 | $6.04M | -26.18% |
| 2020-03-31 | $8.19M | 7.44% |
| 2019-12-31 | $7.62M | 8.41% |
| 2019-09-30 | $7.03M | -43.89% |
| 2019-06-30 | $12.53M | 71.17% |
| 2019-03-31 | $7.32M | -31.12% |
| 2018-12-31 | $10.63M | 17.38% |
| 2018-09-30 | $9.05M | 96.34% |
| 2018-06-30 | $4.61M | 16.14% |
| 2018-03-31 | $3.97M | 29.94% |
| 2017-12-31 | $3.06M | -86.72% |
| 2017-09-30 | $23.02M | 663.60% |
| 2017-06-30 | $3.01M | -0.03% |
| 2017-03-31 | $3.02M | -0.69% |
| 2016-12-31 | $3.04M | -76.67% |
| 2016-09-30 | $13.02M | 333.26% |
| 2016-06-30 | $3.00M | 10.85% |
| 2016-03-31 | $2.71M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Seres Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Seres Therapeutics Revenue Breakdown
Seres Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 |
|---|---|
| License And Service | $27.19M |
Seres Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 19: License And Service (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| License And Service | $5.28M | $10.20M | $8.68M | $4.27M |
| Grant | - | - | - | $341.00K |
Seres Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 19: License And Service (100.00%).
Seres Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 |
|---|---|
| License And Service | $27.19M |
Seres Therapeutics's latest annual revenue breakdown by geography, as of Dec 19: License And Service (100.00%).
Quarterly Revenue by Country
| Country | Dec 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| License And Service | $5.28M | $10.20M | $8.68M | $4.27M |
| Grant | - | - | - | $341.00K |
Seres Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 19: License And Service (100.00%).
MCRB Revenue FAQ
What is Seres Therapeutics’s yearly revenue?
Seres Therapeutics's yearly revenue for 2023 was $126.32M, representing an increase of 1672.24% compared to 2022. The company's yearly revenue for 2022 was $7.13M, representing a decrease of -95.08% compared to 2021. MCRB's yearly revenue for 2021 was $144.93M, representing an increase of 336.33% compared to 2020.
What is Seres Therapeutics’s quarterly revenue?
Seres Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). MCRB's quarterly revenue for Q4 2023 was $64K, a -79.35% decrease from the previous quarter (Q3 2023), and a -93.44% decrease year-over-year (Q4 2022).
What is Seres Therapeutics’s revenue growth rate?
Seres Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -12.84%, and for the last 5 years (2019-2023) was 266.11%.
What are Seres Therapeutics’s revenue streams?
Seres Therapeutics's revenue streams in c 19 are License And Service
What is Seres Therapeutics’s main source of revenue?
For the fiscal year ending Dec 19, the largest source of revenue of Seres Therapeutics was License And Service. This segment made a revenue of $27.19M, representing 100.00% of the company's total revenue.